Insights

Insights

LINTRIS brings together original analysis, external publications and selected media commentary on health policy, biopharma innovation and global health governance.

For in-depth analysis and perspective, visit China Health Pulse — our founder’s newsletter and podcast on China’s impact on patients, policy and the future of global health.

__________________________________________________________

Publications

China’s Evolving Global Health Leadership – Gareth Jones, Zhida Shang, Ruby Wang, Think Global Health, 13 Jan 2026

China Rewrites Global Health Leadership as US Retreats From WHO – Ruby Wang, Nikkei Asia, 15 July 2025

Ask the Experts: China and the Future of Global Aid – Ruby Wang & Felix Brender, IDEAS, London School of Economics, 18th June 2025

Unravelling Progress: The US Exit From The WHO And Its Global Consequences Bailey Johnson, Tammy Bui, Ruby Wang, Joseph Wilson and Cecilia Wang, Health Affairs, 3 Feb, 2025

__________________________________________________________

Media Interviews – News/Podcast

Pharma Bets Big on Chinese Drugmakers – Savannah Billman, The Wire China, 5 April 2026

AI Meets Healthcare in China: Can Technology Fix a Fragmented System, with Winnie Yip & Ruby Wang – Lizzi Lee, Asia Society Policy Institute, Center for China Analysis, 18 March 2026

China’s overstretched healthcare looks to AI boom – Rebecca Bailey, AFP, 3 March 2026

Jack Ma-Backed Ant Bets on AI Health in $69 billion Sector Race – Lulu Chen & Amber Tong, Bloomberg News, 10th Feb 2026

China’s Biotech Rise and the Future of Global Health – Perspectives with Wenchi, 14 Jan 2026

The Hale Report, with Ruby Wang – Lyric Hughes Hale, EconVue, 2 Jan 2026

The changing shape of Chinese aid to Africa – The Economist, 27 Nov 2025

China’s Search for an AI Magic Cure – Rachel Cheung, The Wire China, 14 Dec 2025

How Tech is Driving China’s Healthcare System: Q&A with Ruby Wang – Robert Postings, The Wire China, 14th Sept 2025

China and the Future of Global Aid, with Ruby Wang – Asia Scotland Institute Podcast, 28th Aug 2025

Mapping Noteworthy Startups in China’s Healthcare Sector – Aya Lin, TechinAsia, 21 June 2025

Big Pharma Faces Headwinds in China as Vaccine Sales Decline – Jenna Philpott, Pharmaceutical Technology, 26 March 2025

China Ramps Up Investment in Africa to Build a Health Silk Road – Hannah Crowe, The Telegraph, 27 Dec 2024

__________________________________________________________

News

2025 ODI Global Advisory‘s Inaugural International Development Conference in Bangkok, Thailand – “Ideas Across Borders: How Economies Grow Through Learning”

LINTRIS Founding Director Ruby Wang spoke on a panel about the evolving global health economy with Madhav Joshi, Vera Siesjö, and Hans Peter Lankes, reflecting on how the pace, scale and efficiency of China’s health innovation – particularly its global biotech revolution and domestic digital health transformation – shows us a great deal about how systems can learn and build capability under constraint, with increasing relevance for both developing and developed countries.

There were incredibly rich insights from speakers including Previous Ministers of India and Pakistan, AIIB, JICA, DFID and others into how economies learn more broadly, from Asia’s long experience of growth through adaptation and policy learning, to the importance of teaching, experimentation and institutional memory in solving complex economic challenges.

2024 Digital Health Panel at World Health Organisation Headquarters in Geneva, Switzerland

LINTRIS Health founder Ruby Wang was invited to moderate the “Impact of Tech on Global Health” panel at WHO Headquarters in July 2024, alongside Andy Pattison, WHO Digital Channels Lead, Awa Babington-Ashaye, Ph.D, founder of ADENIUM HEALTHCARE & Riccardo Lampariello, CEO of D-tree, as part of a National Committee on U.S.-China Relations Global Health Experts Seminar.

The three day conference also heard from health leaders incl Ilona Kickbusch of Geneva Graduate Institute global health centre, Joel Rehnstrom prev of UNAIDS, Judith Moore at World Economic Forum, as well as health attaches of US & China missions to UN Matthew Lim and Shi Qi, as well as NCUSCR president Stephen Orlins, and Schwarzman Scholars Senior Director & China Health expert Joan Kaufman, on topics including global health governance/pandemic treaty, health financing, health diplomacy, climate x health.

2024 London Business School’s China Business Forum

Dr Wang was invited to speak at London Business School’s 13th China Business Forum in May 2024 in the “Healthcare Investments” panel moderated by Dr. Jerry Wu , alongside Dan Liu , Rui Ma and Wei Peng. Topics discussed covered the most recent advances in digital health, not only for advancing clinical outcomes and optimising care system operations in order to solve shared UK-China health challenges such as ageing populations and pandemic potential disease but also in addressing innovation, biotech R&D and personalised medicine – starting from the lab.

2024 UK-China Health Policy Exchange on Chronic Obstructive Pulmonary Disease

On 1st February 2024, LINTRIS Health was proud to lead the project delivery of the 2024 UK-China Policy Exchange on Chronic Obstructive Pulmonary Disease, a high-level collaboration between China Centre for Economic Exchanges and the British Embassy Beijing.

COPD is one of the major chronic diseases for the global population. It presents huge health burdens for China today – a challenge that is shared by the UK.

This technical exchange across key senior experts across both countries enabled sharing of best practices on sustainability and affordability of COPD management in Primary Care.

For this bilateral exchange, British Embassy Beijing’s Foreign, Commonwealth and Development Office Minister Counsellor Matthew Moody and Department for Business and Trade Health Counsellor Rahul Agarwal met with CCIEE’s Minister Bi Jingquan. Experts on respiratory and primary care across UK and China government, academia and clinical practice, came together in person in Beijing and online from the UK to engage in meaningful exchanges. 

UK Key Opinion leaders included Prof Sir Chris Ham, CoChair NHS Assembly, previous CEO The King’s Fund and Sarah Woolnough, current CEO, The King’s Fund; Dr Jonathan Fuld and Dr Kiren Collison, Directors of Respiratory and Primary Care at NHS England, Dr Katherine Hickman, Exec Chair at UK Primary Care Society, Dr Richard Russell, Clinical Director, Hampshire Community Integrated Respiratory Service, Prof Sir Peter J. Barnes FRS, FMedSci of the National Heart & Lung Institute and Rt Hon. Prof. Paul Burstow, former UK Minister of Health, Kasey Tobin from Department of Health and Social Care.

2023 The China Project Entrepreneurship Award

In May 2023, LINTRIS Health received the prestigious Entrepreneurship Award at the SupChina Women’s Gala in New York, hosted by The China Project. It was an honour to be recognised for our achievements.